Osteochondroma epidemiology and demographics
|
Osteochondroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Osteochondroma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Osteochondroma epidemiology and demographics |
|
Risk calculators and risk factors for Osteochondroma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Osteochondroma is the most common benign tumor of the bone.[1] The incidence of osteochondroma is approximately 0.9 per 100,000 individuals in the general population. The incidence of osteochondroma decreases with age; the median age at diagnosis is between 10 to 13 years.[2] Males are more commonly affected with osteochondroma than females. Osteochondroma usually affects individuals of the Caucasian race.[3]
Epidemiology and Demographics
Prevalence
- Osteochondroma is the most common benign bone tumor among general population.
- Osteochondroma is considered an uncommon tumor among adults, as it comprises fewer than 20% of all bone tumors among that age group.[4]
Incidence
- The overall adjusted incidence rate of osteochondroma is approximately 0.9 per 100,000 individuals in the general population.[3]
Age
- The incidence of osteochondroma decreases with age; the median age at diagnosis is between 10 to 13 years.
- The subtypes of osteochondroma has an influence on the age of presentation such as:
- Hereditary multiple osteochondroma presents among younger children or newborns
- Single osteochondroma presents among infants and adolescents
Gender
- Males are more commonly affected with osteochondroma than females. The male to female ratio is approximately 2 to 1.[5]
- In multiple osteochondromas, males are more commonly affected by severe manifestations than females.
Race
- Osteochondroma usually affects individuals of the Caucasian race.
- The incidence rate of osteochondroma among Caucasians is 2 per 100,000 individuals in the general population.[3]
References
- ↑ Murphey MD, Choi JJ, Kransdorf MJ, Flemming DJ, Gannon FH (2000). "Imaging of osteochondroma: variants and complications with radiologic-pathologic correlation". Radiographics : a Review Publication of the Radiological Society of North America, Inc. 20 (5): 1407–34. doi:10.1148/radiographics.20.5.g00se171407. PMID 10992031.
- ↑ Saglik Y, Altay M, Unal VS, Basarir K, Yildiz Y (2006). "Manifestations and management of osteochondromas: a retrospective analysis of 382 patients". Acta Orthopaedica Belgica. 72 (6): 748–55. PMID 17260614.
- ↑ 3.0 3.1 3.2 Kitsoulis P, Galani V, Stefanaki K, Paraskevas G, Karatzias G, Agnantis NJ, Bai M (2008). "Osteochondromas: review of the clinical, radiological and pathological features". In Vivo (Athens, Greece). 22 (5): 633–46. PMID 18853760.
- ↑ Ellison JD, Christian VK, Johnson RL, Warren BJ, Collins MA (1992). "Effect of musculoskeletal development on the prediction of body density in females". The Journal of Sports Medicine and Physical Fitness. 32 (2): 175–9. PMID 1434587.
- ↑ Diagnostic Radiology: Musculoskeletal Imaging: Osteochondroma. WikiBooks.(2015)https://en.wikibooks.org/wiki/Diagnostic_Radiology/Musculoskeletal_Imaging/Tumors_Basic/Osteochondroma Accessed on January 28, 2016